Logo

Garrett Lam

Jun 21, 2018

Garrett Lam will join Sera Prognostics as chief medical officer starting Sept. 4. He will direct all clinical development activities for the firm and direct a group of clinical operations professionals in support of the firm's collaborations. Lam is currently a professor and chairman of obstetrics and gynecology at the University of Tennessee College of Medicine-Chattanooga. Lam replaces Durlin Hickok, who has been Sera's CMO since 2011. Hickok will continue as an advisor to Sera. 

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.